The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Caspase activation precedes and leads to tangles
Open accessAbstract
Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death, severe cytological abnormalities, and markers of caspase activation and apoptosis, leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational- and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence suggests that executioner caspases 3 and 7 may contribute to tau, the protein responsible for forming NFTs, pathology by cleaving tau after Asp421 to yield a cytotoxic Δtau fragment (Rissman et al., 2004; Rohn et al., 2008; de Calignon et al., 2010).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“may contribute to cognitive decline”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the early cleavage of tau by these caspases initiates tau aggregation and phosphorylation”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
In the citing paper
“Mitochondrial abnormalities, synaptic loss and dysfunction, altered axonal transport, and activation of cell death pathways (including caspase activation and inflammatory responses) have all been directly or indirectly implicated as consequences of tau mislocalization or oligomerization (20, 40, 43–52).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“For example, through direct visualization of the cortex of Tg4510 P301L mice by multiphoton microscopy, Hyman and colleagues were able to determine that caspase activation, and neuronal death, appeared in many instances to precede tangle formation.”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Indeed, tangles forming did not lead to neuronal death over the course of the several-month imaging period (43, 51).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Recent data suggest that intracellular protein aggregates of tau have the capacity to seed aggregation of native tau proteins and might propagate their misfolded state in a prion-like manner.”
From Propagation of Tau Pathology in a Model of Early Alzheimer's Disease (2012) · cites this paper as de Calignon et al., 2010
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [266]
In the citing paper
“whereas tau tangles alone are not sufficient to cause neuronal death”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as de Calignon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Self-citationControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationAugustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
Self-citationCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
Self-citationTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 525
Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation
Mead, E., Kestoras, D., Gibson, Y., Hamilton, L., Goodson, R. J., Jones, S., Eversden, S., Davies, P., O’Neill, M. J., Hutton, M. L., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150960 · Cited by 26
Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses
Wegmann, S., Bennett, R. E., Amaral, A. C. S., & Hyman, B. T. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.014 · Cited by 29
Self-citationSutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26
Lawson, V., Haigh, C. L., Roberts, B. R., Kenche, V. B., Klemm, H. M. J., Masters, C. L., Collins, S. J., Barnham, K. J., & Drew, S. C. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100068x · Cited by 26
Maria Jose Perez, J., Ibarra‐García‐Padilla, R., Tang, M., Porter, G. A., Johnson, G. V. W., & Quintanilla, R. A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166898 · Cited by 25
The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology
Simón, D., Hernández, F., & Avila, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00074 · Cited by 25
GSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses
Hotokezaka, Y., Katayama, I., van Leyen, K., & Nakamura, T. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.90 · Cited by 25
Caspase-Mediated Truncation of Tau Potentiates Aggregation
Lee, S., & Shea, T. B. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/731063 · Cited by 25
Spires-Jones, T. L., Calignon, A. D., Meyer-Luehmann, M., Bacskai, B. J., & Hyman, B. T. (2011) · Methods · doi:10.1016/j.ymeth.2010.12.009 · Cited by 24
Self-citationPhysiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system
Mielenz, D., & Gunn-Moore, F. (2016) · Biochemical Journal · doi:10.1042/bcj20160168 · Cited by 24
Jung, H. J., Park, S. S., Mok, J. O., Lee, T. K., Park, C. S., & Park, S. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.012 · Cited by 25
Garringer, H. J., Murrell, J. R., Sammeta, N., Gnezda, A., Ghetti, B. F., & Vidal, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056426 · Cited by 24
Biundo, F., d’Abramo, C., Tambini, M. D., Zhang, H., Prete, D. D., Vitale, F., Giliberto, L., Arancio, O., & D'adamio, L. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.165 · Cited by 25
Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation
Park, J., Choi, H., Kim, Y. D., Kim, S.-H., Kim, Y., Gwon, Y., Lee, D. Y., Park, S., Heo, W. D., & Jung, Y. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01003-y · Cited by 23
Heparan Sulfate Proteoglycans in Tauopathy
Zhu, Y., Gandy, L. A., Zhang, F., Liu, J., Wang, C., Blair, L. J., Linhardt, R. J., & Wang, L. (2022) · Biomolecules · doi:10.3390/biom12121792 · Cited by 27
Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3
Tapia-Monsalves, C., Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103861 · Cited by 24
Aneuploidy in Lewy body diseases
Yang, Y., Shepherd, C. E., & Halliday, G. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.016 · Cited by 23
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
Croft, C. L., Goodwin, M. S., Ryu, D. H., Lessard, C. B., Tejeda, G., Marrero, M., Vause, A. R., Paterno, G., Cruz, P. E., Lewis, J. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02264-9 · Cited by 26
Neurosteroids and Oxysterols as Potential Therapeutic Agents for Glaucoma and Alzheimer’s Disease
Ishikawa, M., Yoshitomi, T., Covey, D. F., Zorumski, C. F., & Izumi, Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000356 · Cited by 22
Theofilas, P., Piergies, A. M. H., Oh, I. M., Lee, Y. B., Li, S. H., Pereira, F. L., Petersen, C., Ehrenberg, A. J., Eser, R. A., Ambrose, A. J., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12819 · Cited by 22
Olesen, M. A., & Quintanilla, R. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03434-4 · Cited by 23
Löffler, T., Flunkert, S., Taub, N., Schofield, E., Ward, M. A., Windisch, M., & Hutter‐Paier, B. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9716-6 · Cited by 23
Riechers, S., Butland, S. L., Deng, Y., Skotte, N. H., Ehrnhoefer, D. E., Russ, J., Lainé, J., Laroche, M., Pouladi, M. A., Wanker, E. E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw036 · Cited by 22
Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons
Oakley, D. H., Klickstein, N., Commins, C., Chung, M., Dujardin, S., Bennett, R. E., Hyman, B. T., & Frosch, M. P. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2590-20.2021 · Cited by 18
Self-citationTransgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts
Esteves, S., Duarte‐Silva, S., & Maciel, P. (2016) · Medicinal Research Reviews · doi:10.1002/med.21425 · Cited by 22
Common mechanisms in neurodegeneration
Ávila, J. (2010) · Nature Medicine · doi:10.1038/nm1210-1372a · Cited by 21
de Souza, I. D., & Queiroz, M. E. C. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04631-9 · Cited by 20
Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
Lawand, N., Saadé, N. E., El‐Agnaf, O. M. A., & Safieh‐Garabedian, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1062877 · Cited by 19
Chaves, R. S., Kazi, A. I., Silva, C. M., Almeida, M. F., Lima, R. S., Carrettiero, D. C., Demasi, M., & Ferrari, M. (2016) · IBRO Reports · doi:10.1016/j.ibror.2016.09.001 · Cited by 20
Hromádková, L., Kolarova, M., Jankovičová, B., Bartoš, A., Říčný, J., Bı́lková, Z., & Řı́pová, D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.017 · Cited by 18
Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer’s cases
Kamath, T. V., Klickstein, N., Commins, C., Fernandes, A. R., Oakley, D. H., Frosch, M. P., Hyman, B. T., & Dujardin, S. (2021) · Brain Communications · doi:10.1093/braincomms/fcab096 · Cited by 17
Self-citationChaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy
Liu, Y., Tan, M., & Tan, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04640-9 · Cited by 22
NMR Studies of Tau Protein in Tauopathies
Kitoka, K., Škrabana, R., Gašparik, N., Hritz, J., & Jaudzems, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.761227 · Cited by 17
Lin, W.-L., Dickson, D. W., & Sahara, N. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822ac9c9 · Cited by 19
Memorcise and Alzheimer’s disease
Loprinzi, P. D., Frith, E., & Ponce, P. (2018) · The Physician and Sportsmedicine · doi:10.1080/00913847.2018.1445932 · Cited by 17
Swainsonine-induced apoptosis pathway in cerebral cortical neurons
Lu, H., Ma, F., Zhang, L., Wang, J., Wu, C., & Zhao, B. (2015) · Research in Veterinary Science · doi:10.1016/j.rvsc.2015.07.005 · Cited by 17
Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases
Longhena, F., Spano, P., & Bellucci, A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_60 · Cited by 17
Yeap, J., Sathyaprakash, C., Toombs, J., Tulloch, J., Scutariu, C., Rose, J. L., Burr, K., Davies, C., Colom‐Cadena, M., Chandran, S., et al. (2022) · Brain and Neuroscience Advances · doi:10.1177/23982128221086464 · Cited by 16
Self-citationCrespo‐Biel, N., Theunis, C., Borghgraef, P., Lechat, B., Devijver, H., Maurin, H., & LEUVEN, F. V. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.016 · Cited by 15
Reece, A. S. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.047 · Cited by 17
Chi, H., Lee, S., Shiu, R.-H., Han, R., Hsieh, C.-P., Wei, T.-M., Lo, C., Chang, H.-Y., & Sang, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-70423-1 · Cited by 17
Smith, G. S. T., Voyer-Grant, J. A. M., & Harauz, G. (2012) · Journal of Visualized Experiments · doi:10.3791/3422 · Cited by 16
Noël, A., Foveau, B., & LeBlanc, A. C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03506-0 · Cited by 16
Bai, Q., Shao, E., Ma, D., Jiao, B., Scheetz, S. D., Hartnett, K. A., Ильин, В. Н., Aizenman, E., Kofler, J., & Burton, E. A. (2024) · Nature Communications · doi:10.1038/s41467-024-52173-0 · Cited by 16
Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias
Pockes, S., Walters, M. A., & Ashe, K. H. (2022) · Translational research · doi:10.1016/j.trsl.2022.10.009 · Cited by 15
Elseweidy, M. M., Mahrous, M., Ali, S. I., Shaheen, M. A., & Younis, N. N. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00672-1 · Cited by 15
Smaller grey matter volume in the central olfactory system in mild cognitive impairment
Jobin, B., Boller, B., & Frasnelli, J. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112325 · Cited by 15
Pluta, R. M., Bogucka‐Kocka, A., Bogucki, J., Kocki, J., & Czuczwar, S. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240401 · Cited by 15
Li, Y., Liu, Y.-J., Zhang, W., Luo, S.-F., Zhou, X., & He, G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308103 · Cited by 16
Macchi, B., Marino‐Merlo, F., Frezza, C., Cuzzocrea, S., & Mastino, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8641-9 · Cited by 15
Protein Truncation as a Common Denominator of Human Neurodegenerative Foldopathies
Jadhav, S., Žilka, N., & Novák, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8440-8 · Cited by 15
Paradoxical role of PKA inhibitor on amyloidβ-induced memory deficit
Amini, E., Nassireslami, E., Payandemehr, B., Khodagholi, F., Foolad, F., Khalaj, S., Hamedani, M. P., Azimi, L., & Sharifzadeh, M. S. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.029 · Cited by 16
Delatour, B., Epelbaum, S., Petiet, A., & Dhénain, M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/604853 · Cited by 18
Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
da Costa, P. J., Hamdane, M., Buée, L., & Martin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020241 · Cited by 16
Anchored FRET sensors detect local caspase activation prior to neuronal degeneration
Figueroa, R. A., Ramberg, V., Gatsinzi, T., Samuelsson, M., Zhang, M., Iverfeldt, K., & Hallberg, E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-35 · Cited by 14
Cell Death Related Proteins Beyond Apoptosis in the CNS
Bahatyrevich-Kharitonik, B., Medina-Guzman, R., Flores-Cortes, A., García-Cruzado, M., Kavanagh, E. T., & Burguillos, M. Á. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.825747 · Cited by 14
The Earliest Tau Dysfunction in Alzheimer's Disease?
Voss, K., Koren, J., & Dickey, C. A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.020 · Cited by 14
Park, S. S., Jung, H., Kim, Y., Park, T. K., Kim, C., Choi, H., Mook‐Jung, I. H., Koo, E. H., & Park, S. A. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12032 · Cited by 14
Kim, J., Choi, I.-Y., Duff, K., & Lee, P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2298-5 · Cited by 14
Mitophagy in Alzheimer's disease and its potential as a therapeutic target
Wei, J., Xiao, T., Lyu, J., Zhao, Y., Zhang, Y., Du, X., He, Y., Zhao, M., Yang, X., Yao, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107162 · Cited by 13
Müller, I., Lamers, M. B. A. C., Ritchie, A. J., Dominguez, C., Muñoz-Sanjuán, I., & Kiselyov, A. S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.041 · Cited by 13
Wang, Y., Sørensen, M. G., Zheng, Q., Zhang, C., Karsdal, M. A., & Henriksen, K. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/209409 · Cited by 13
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
Campo, M. D., Oliveira, C. R., Scheper, W., Zwart, R., Korth, C., Müller‐Schiffmann, A., Kostallas, G., Biverstål, H., Presto, J., Johansson, J., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1769-y · Cited by 12
A New Apo-Caspase-6 Crystal Form Reveals the Active Conformation of the Apoenzyme
Müller, I., Lamers, M. B. A. C., Ritchie, A. J., Park, H., Dominguez, C., Muñoz-Sanjuán, I., Maillard, M. C., & Kiselyov, A. S. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.05.020 · Cited by 12
Zaki, M. O., El-Desouky, S., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01023-w · Cited by 12
RetractedTau Protein: Function and Pathology
Rosenmann, H., Blum, D. L., Kayed, R., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/707482 · Cited by 12
Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13
Emmerson, J. T., Malcolm, J. C., Carmo, S. D., Nguyen, P., Breuillaud, L., Martínez-Trujillo, J., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106317 · Cited by 11
Rizzi, L., & Grinberg, L. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01744-9 · Cited by 12
Interplay between glycogen synthase kinase‐3β and tau in the cerebellum of Hsp27 transgenic mouse
Wang, S., Toth, M. E., Bereczki, E., Sántha, M., Guan, Z., Winblad, B. G., & Pei, J.-J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22660 · Cited by 11
Non-Apoptotic Role of Apoptotic Caspases in the Drosophila Nervous System
Plaza, S. C., & Su, T. T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839358 · Cited by 11
Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau
Asadzadeh, J., Ruchti, E., Jiao, W., Limoni, G., MacLachlan, C., Small, S. A., Knott, G., Santa-Maria, I., & McCabe, B. D. (2022) · Nature Communications · doi:10.1038/s41467-022-32683-5 · Cited by 14
The C-Terminus of Tau Protein Plays an Important Role in Its Stability and Toxicity
Geng, J., Xia, L., Li, W., & Dou, F. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0314-7 · Cited by 11
Jean-Louis, T. L., Rockwell, P., & Figueiredo‐Pereira, M. E. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.009 · Cited by 11
In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line
Sahara, N., Shimojo, M., Ono, M., Takuwa, H., Febo, M., Higuchi, M., & Suhara, T. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00663 · Cited by 11
Vogels, T., Vargová, G., Brezováková, V., Quint, W. H., & Hromádka, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200047 · Cited by 11
Retinal Changes in Transgenic Mouse Models of Alzheimer’s Disease
Guo, L., Ravindran, N., Shamsher, E., Hill, D., & Cordeiro, M. F. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210414113634 · Cited by 13
Dahal, A., Karthivashan, G., & Kar, S. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.02.010 · Cited by 12
Proteomic identification of synaptic caspase substrates
Victor, K. G., Heffron, D. S., Sokolowski, J. D., Majumdar, U., LeBlanc, A. C., & Mandell, J. W. (2017) · Synapse · doi:10.1002/syn.22014 · Cited by 11
Behroozi, Z., Askarpour, H., & Baghcheghi, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261415807 · Cited by 10
Vera, D. M., López-Gambero, A. J., Navarro, J. A., Sanjuan, C., Baixerás, E., Decara, J. M., & de Fonseca, F. R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379015 · Cited by 10
Fertan, E., Meisl, G., & Klenerman, D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70462 · Cited by 10
Reversing inflammatory diseases via trained immunity: mechanisms, challenges, and prospects
Xu, W., Guo, Z., Xu, T., Chen, J., Chen, L., & Xu, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1666233 · Cited by 14
Tau aggregation and its relation to selected forms of neuronal cell death
Tolkovsky, A. M., & Spillantini, M. G. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210030 · Cited by 13
Yao, J., He, Z., You, G., Liu, Q., & Li, N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080402 · Cited by 9
Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2021) · Oxygen · doi:10.3390/oxygen1020010 · Cited by 11
γ‐secretase complexes containing caspase‐cleaved presenilin‐1 increase intracellular Aβ42/Aβ40 ratio
Hedskog, L., Petersen, C. H., Svensson, A., Welander, H., Tjernberg, L. O., Karlström, H., & Ankarcrona, M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01208.x · Cited by 11
Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells
Catalina, M. O., Bermejo, M. C., Argent, R., Alonso, J. C., Cuenda, A., Lorenzo, M. J. V., & Centeno, F. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25579 · Cited by 10
Tau aggregation and its relation to selected forms of neuronal cell death.
Tolkovsky, A. M., & Spillantini, M. G. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.80530 · Cited by 9
Le, Q.-U., Lay, H., & Wu, M. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12718 · Cited by 9
Orr, M. E., Pitstick, R., Canine, B., Ashe, K. H., & Carlson, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039328 · Cited by 9
Self-citationNeurobiology of Alzheimer’s Disease
Wong, P. C., Savonenko, A. V., Li, T., & Price, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00046-8 · Cited by 9
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue
Tofaris, G. K., & Schapira, A. H. V. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.002 · Cited by 9
Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells
Sinclair, P., & Kabbani, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270479 · Cited by 8
The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8
Gancia, P., & Pomero, G. (2010) · PubMed · Cited by 8
Minini, L., Ferraro, F., Cancela, S., & Merlino, A. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.06.118 · Cited by 8
Steuer, E. L., Kemper, L. J., Hlynialuk, C. J. W., Leinonen-Wright, K., Montonye, M. L., Lapcinski, I. P., Forster, C. L., Ashe, K. H., & Liu, P. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0543-22.2022 · Cited by 9
Metadata
- Authors
- de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- McLaughlin Research Institute (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2010-03-31
- Volume
- 464
- Issue
- 7292
- Pages
- 1201-1204
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3091360
- OpenAlex
- W2100026237
- Cited by
- 517
- References
- 31
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 12 · 2023: 30 · 2022: 24 · 2021: 28 · 2020: 26 · 2019: 19 · 2018: 26 · 2017: 38 · 2016: 40 · 2015: 39 · 2014: 26 · 2013: 48 · 2012: 54
- FWCI
- 39.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institute on Aging (AG-08487, R01AG026249, R01AG008487, AG026249, P50AG005134, K99AG033670, P30AG062421)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- caspase activation, neurofibrillary tangles, tau protein, Alzheimer's disease, frontotemporal dementia, tau transgenic mice, neuronal survival, neurodegeneration, tau truncation, APOE ε4, APOE3, APOE2, APOE genotype, multiphoton imaging, tau aggregation
- MeSH terms
- Animals, Brain, Enzyme Activation, Humans, Mice, Transgenic, Neurons, Protein Processing, Post-Translational, Solubility, Time Factors, Neurofibrillary Tangles, tau Proteins, Cell Death, Caspases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
